References
- Adamson, S. J., Sellman, J. D., & Frampton, C. M. (2009). Patient predictors of alcohol treatment outcome: A systematic review. Journal of Substance Abuse Treatment, 36(1), 75–86. https://doi.org/https://doi.org/10.1016/j.jsat.2008.05.007
- Alterman, A. I., McLellan, A. T., & Shifman, R. B. (1993). Do substance abuse patients with more psychopathology receive more treatment? The Journal of Nervous and Mental Disease, 181(9), 576–582. https://doi.org/https://doi.org/10.1097/00005053-199309000-00009
- Andersson, H. W., Steinsbekk, A., Walderhaug, E., Otterholt, E., & Nordfjaern, T. (2018). Predictors of dropout from inpatient substance use treatment: A prospective cohort study. Substance Abuse, 12, 1178221818760551. https://doi.org/https://doi.org/10.1177/1178221818760551
- Antonovsky, A. (1993). The structure and properties of the sense of coherence scale. Social Science & Medicine, 36(6), 725–733. https://doi.org/https://doi.org/10.1016/0277-9536(93)90033-z
- APA – American Psychiatric Association. (2006). Practice guideline for the treatment of patients with substance use disorders. American Psychiatric Publishing Inc.
- Arias, A. J., Gelernter, J., Grace, H., Roger, D. W., Brady, K. T., Farrer, L., & Kvanzler, H. R. (2008). Correlates of co-occurring ADHD in drug-dependent subjects: Prevalence and features of substance dependence and psychiatric disorders. Chest, 123, 1730–1739. https://doi.org/https://doi.org/10.1016/j.addbeh.2008.05.003
- Ball, S. A., Carroll, K. M., Canning-Ball, M., & Rounsaville, B. J. (2006). Reasons for dropout from drug abuse treatment: Symptoms, personality, and motivation. Addictive Behaviors, 31(2), 320–330. https://doi.org/https://doi.org/10.1016/j.addbeh.2005.05.013
- Barkley, R. A., Murphy, K. R., & Fischer, M. (2010). ADHD in adults: What the science says. Guilford Press.
- Barrowclough, C., Haddock, G., Tarrier, N., Lewis, S. W., Moring, J., O'Brien, R., Schofield, N., & McGovern, J. (2001). Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. The American Journal of Psychiatry, 158(10), 1706–1713. https://doi.org/https://doi.org/10.1176/appi.ajp.158.10.1706
- Bastle, R. M., Oliver, R. J., Gardiner, A. S., Pentkowski, N. S., Bolognani, F., Allan, A. M., Chaudhury, T., St Peter, M., Galles, N., Smith, C., Neisewander, J. L., & Perrone-Bizzozero, N. I. (2018). In silico identification and in vivo validation of miR-495 as a novel regulator of motivation for cocaine that targets multiple addiction-related networks in the nucleus accumbens. Molecular Psychiatry, 23(2), 434–443. https://doi.org/https://doi.org/10.1038/mp.2016.238
- Boleloucký, Z., Plevová, J., & Smulevič, A. B. (1993). Hraniční stavy v psychiatrii [Borderline states in psychiatry]. Grada Avicenum.
- Breda, C. S., & Heflinger, C. A. (2007). The impact of motivation to change on substance use among adolescents in treatment. Journal of Child & Adolescent Substance Abuse, 16(3), 109–124. https://doi.org/https://doi.org/10.1300/J029v16n03_06
- Bukstein, O. G., & Roberto, A. (2018). Moodiness in patients with ADHD and substance use disorders. In W. B. Daviss (Ed.), Moodiness in ADHD (pp. 145–159). Springer. https://doi.org/https://doi.org/10.1007/978-3-319-64251-2_10
- Cady, M. E., Winters, K. C., Jordan, D. A., Solberg, K. B., & Stinchfield, R. D. (1996). Motivation to change as a predictor of treatment outcome for adolescent substance abusers. Journal of Child & Adolescent Substance Abuse, 5(1), 73–91. https://doi.org/https://doi.org/10.1300/J029v05n01_04
- Cornelius, T., Earnshaw, V. A., Menino, D., Bogart, L. M., & Levy, S. (2017). Treatment motivation among caregivers and adolescents with substance use disorders. Journal of Substance Abuse Treatment, 75, 10–16. https://doi.org/https://doi.org/10.1016/j.jsat.2017.01.003
- Cubillo, A., Halari, R., Smith, A., Taylor, E., & Rubia, K. (2012). A review of fronto-striatal and fronto-cortical brain abnormalities in children and adults with Attention Deficit Hyperactivity Disorder (ADHD) and new evidence for dysfunction in adults with ADHD during motivation and attention. Cortex, 48(2), 194–215. https://doi.org/https://doi.org/10.1016/j.cortex.2011.04.007
- de Graaf, R., Kessler, R. C., Fayyad, J., ten Have, M., Alonso, J., Angermeyer, M., Borges, G., Demyttenaere, K., Gasquet, I., de Girolamo, G., Haro, J. M., Jin, R., Karam, E. G., Ormel, J., & Posada-Villa, J. (2008). The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: Results from the WHO World Mental Health Survey Initiative. Occupational and Environmental Medicine, 65(12), 835–842. https://doi.org/https://doi.org/10.1136/oem.2007.038448
- De Leon, G., Melnick, G., Kressel, D., & Jainchill, N. (1994). Circumstances, motivation, readiness, and suitability (the CMRS scales): Predicting retention in therapeutic community treatment. The American Journal of Drug and Alcohol Abuse, 20(4), 495–515. https://doi.org/https://doi.org/10.3109/00952999409109186
- De Leon, G., Melnick, G., Thomas, G., Kressel, D., & Wexler, H. K. (2000). Motivation for treatment in a prison-based therapeutic community. The American Journal of Drug and Alcohol Abuse, 26(1), 33–46. https://doi.org/https://doi.org/10.1081/ada-100100589
- Deane, F. P., Wootton, D. J., Hsu, C. I., & Kelly, P. J. (2012). Predicting dropout in the first 3 months of 12-step residential drug and alcohol treatment in an Australian sample. Journal of Studies on Alcohol and Drugs, 73(2), 216–225. https://doi.org/https://doi.org/10.15288/jsad.2012.73.216
- Derogatis, L. R. (1977). The SCL-90 manual I: Scoring, administration and procedures for the SCL-90. Clinical Psychometric Research.
- DiClemente, C. C., Bellino, L. E., & Neavins, T. M. (1999). Motivation for change and alcoholism treatment. Alcohol Research and Health, 23(2), 87–92.
- DiClemente, C. C., Nidecker, M., & Bellack, A. S. (2008). Motivation and the stages of change among individuals with severe mental illness and substance abuse disorders. Journal of Substance Abuse Treatment, 34(1), 25–35. https://doi.org/https://doi.org/10.1016/j.jsat.2006.12.034
- DiClemente, C. C., Schlundt, D., & Gemmell, L. (2004). Readiness and stages of change in addiction treatment. The American Journal on Addictions, 13(2), 103–119. https://doi.org/https://doi.org/10.1080/10550490490435777
- DIVA 2.0. (2012). Diagnostic interview for ADHD in adults 2.0 (DIVA 2.0). Adult ADHD. Diagnostic Assessment and Treatment. Pearson Assessment and Information BV. The Czech translation for research.
- [EMCDDA] European Monitoring Centre for Drugs & Drug Addiction. (2002). 2002 annual report on the state of the drugs problem in the European Union and Norway. Office for Official Publications of the European Communities.
- Fervaha, G., Takeuchi, H., Foussias, G., Hahn, M. K., Agid, O., & Remington, G. (2018). Achievement motivation in early schizophrenia: Relationship with symptoms, cognition and functional outcome. Early Intervention in Psychiatry, 12(6), 1038–1044. https://doi.org/https://doi.org/10.1111/eip.12405
- Havassy, B. E., Hall, S. M., & Wasserman, D. A. (1991). Social support and relapse: Commonalities among alcoholics, opiate users, and cigarette smokers. Addictive Behaviors, 16(5), 235–246. https://doi.org/https://doi.org/10.1016/0306-4603(91)90016-b
- Hershberger, A. R., Um, M., & Cyders, M. A. (2017). The relationship between the UPPS-P impulsive personality traits and substance use psychotherapy outcomes: A meta-analysis. Drug and Alcohol Dependence, 178, 408–416. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2017.05.032
- Hiller, M. L., Knight, K., Leukefeld, C., & Simpson, D. D. (2002). Motivation as a predictor of therapeutic engagement in mandated residential substance abuse treatment. Criminal Justice and Behavior, 29(1), 56–75. https://doi.org/https://doi.org/10.1177/0093854802029001004
- Honaker, J., King, G., & Blackwell, M. (2011). Amelia II: A program for missing data. Journal of Statistical Software, 45(7), 1–47. https://doi.org/https://doi.org/10.18637/jss.v045.i07
- Kokkevi, A., & Hartgers, C. (1995). EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence. European Addiction Research, 1(4), 208–210. https://doi.org/https://doi.org/10.1159/000259089
- Kooij, J. J. S., & Francken, M. H. (2010). Diagnostic interview for ADHD in adults 2.0 (DIVA 2.0). Adult ADHD. Diagnostic Assessment and Treatment. Pearson Assessment and Information BV.
- Lappan, S. N., Brown, A. W., & Hendricks, P. S. (2020). Dropout rates of in‐person psychosocial substance use disorder treatments: A systematic review and meta‐analysis. Addiction, 115(2), 201–217. https://doi.org/https://doi.org/10.1111/add.14793
- Lenth, R. (2018). emmeans: Estimated marginal means, aka least-squares means [R package]. https://cran.r-project.org/package=emmeans
- Liao, Y.-T., Chen, C.-Y., Ng, M.-H., Huang, K.-Y., Shao, W.-C., Lin, T.-Y., Chen, V. C.-H., & Gossop, M. (2017). Depression and severity of substance dependence among heroin dependent patients with ADHD symptoms. The American Journal on Addictions, 26(1), 26–33. https://doi.org/https://doi.org/10.1111/ajad.12487
- López-Goñi, J. J., Fernández-Montalvo, J., & Arteaga, A. (2012). Addiction treatment dropout: Exploring patients’ characteristics. The American Journal on Addictions, 21(1), 78–85. https://doi.org/https://doi.org/10.1111/j.1521-0391.2011.00188.x
- Magor-Blatch, L., Bhullar, N., Thomson, B., & Thorsteinsson, E. (2014). A systematic review of studies examining effectiveness of therapeutic communities. Therapeutic Communities, 35(4), 168–184. https://doi.org/https://doi.org/10.1108/TC-07-2013-0024
- Malivert, M., Fatséas, M., Denis, C., Langlois, E., & Auriacombe, M. (2012). Effectiveness of therapeutic communities: A systematic review. European Addiction Research, 18(1), 1–11. https://doi.org/https://doi.org/10.1159/000331007
- Matsumoto, T., Kamijo, A., Yamaguchi, A., Iseki, E., & Hirayasu, Y. (2005). Childhood histories of attention-deficit hyperactivity disorders in Japanese methamphetamine and inhalant abusers: Preliminary report. Psychiatry and Clinical Neurosciences, 59(1), 102–105. https://doi.org/https://doi.org/10.1111/j.1440-1819.2005.01340.x
- McLellan, A. T., Luborsky, L., Woody, G. E., O'Brien, C. P., & Druley, K. A. (1983). Predicting response to alcohol and drug abuse treatments. Role of psychiatric severity. Archives of General Psychiatry, 40(6), 620–625. https://doi.org/https://doi.org/10.1001/archpsyc.1983.04390010030004
- Melnick, G., De Leon, G., Hawke, J., Jainchill, N., & Kressel, D. (1997). Motivation and readiness for therapeutic community treatment among adolescents and adult substance abusers. The American Journal of Drug and Alcohol Abuse, 23(4), 485–506. https://doi.org/https://doi.org/10.3109/00952999709016891
- Miller, W. R., & Johnson, W. R. (2008). A natural language screening measure for motivation to change. Addictive Behaviors, 33 (9), 1177–1182. https://doi.org/https://doi.org/10.1016/j.addbeh.2008.04.018
- Miovský, M., Čablová, L., Kalina, K., & Šťastná, L. (2014). The effects of ADHD on the course and outcome of addiction treatment in clients of therapeutic communities: Research design. Adiktologie, 14, 392–400.
- Miovský, M., Kulhánek, A., Šťastná, L., Čablová, L., Rubášová, E., Šefránek, M., & Stastna, L. (2018). Diagnostika a terapie ADHD. Dospělí pacienti a klienti v Adiktologii [ADHD diagnosis and treatment. Adult patients and clients in addictology]. Grada.
- Miovský, M., Lukavská, K., Rubášová, E., Šťastná, L., Šefránek, M., & Gabrhelík, R. (in press). Attention deficit hyperactivity disorder among clients diagnosed with a substance use disorder in therapeutic communities: Prevalence and psychiatric comorbidity. European Addiction Research, https://doi.org/https://doi.org/10.1159/000508571
- Modesto-Lowe, V., Chaplin, M., Soovajian, V., & Meyer, A. (2013). Are motivation deficits underestimated in patients with ADHD? A review of the literature. Postgraduate Medicine, 125(4), 47–52. https://doi.org/https://doi.org/10.3810/pgm.2013.07.2677
- Morey, R. D., & Rouder, J. N. (2018). BayesFactor: Computation of Bayes factors for common designs [R package]. https://cran.r-project.org/package=BayesFactor
- Mravčík, V., Chomynová, P., Grohmannová, K., Janíková, B., Tion Leštinová, Z., Cibulka, J., Fidesova, H., & Vopravil, J. (2017). In V. Mravčík (Ed.), Výroční zpráva o stavu ve věcech drog v České republice v roce 2016 [Annual report on the drug situation 2016 – Czech Republic]. Úřad vlády České republiky.
- Özgen, H., Spijkerman, R., Noack, M., Holtmann, M., Schellekens, A. S., van den Glind, G., Banaschewski, T., Barta, C., Begeman, A., Casas, M., Crunelle, C. L., Blanco, C. D., Dalsgaard, S., Demetrovics, Z., den Boer, J., Dom, G., Eapen, V., Faraone, S. V., Franck, J., González, R. A., … Hendriks, V. (2020). International consensus statement for the screening, diagnosis, and treatment of adolescents with concurrent attention-deficit/hyperactivity disorder and substance use disorder. European Addiction Research, 1–10. https://doi.org/https://doi.org/10.1159/000508385
- R Core Team. (2018). R: A language and environment for statistical computing [Computer software]. https://cran.r-project.org/
- Ramos-Quiroga, J. A., Nasillo, V., Richarte, V., Corrales, M., Palma, F., Ibáñez, P., Michelsen, M., Van de Glind, G., Casas, M., & Kooij, J. J. S. (2019). Criteria and concurrent validity of DIVA 2.0: A semi-structured diagnostic interview for adult ADHD. Journal of Attention Disorders, 23(10), 1126–1135. https://doi.org/https://doi.org/10.1177/1087054716646451
- Reale, L., Bartoli, B., Cartabia, M., Zanetti, M., Costantino, M. A., Canevini, M. P., Termine, C., & Bonati, M., Lombardy ADHD Group. (2017). Comorbidity prevalence and treatment outcome in children and adolescents with ADHD. European Child & Adolescent Psychiatry, 26(12), 1443–1457. https://doi.org/https://doi.org/10.1007/s00787-017-1005-z
- Romano, M., & Peters, L. (2015). Evaluating the mechanisms of change in motivational interviewing in the treatment of mental health problems: A review and meta-analysis. Clinical Psychology Review, 38, 1–12. https://doi.org/https://doi.org/10.1016/j.cpr.2015.02.008
- Rouder, J. N., Speckman, P. L., Sun, D., Morey, R. D., & Iverson, G. (2009). Bayesian t tests for accepting and rejecting the null hypothesis. Psychonomic Bulletin & Review, 16(2), 225–237. https://doi.org/https://doi.org/10.3758/PBR.16.2.225
- Rubášová, E., Kalina, K., Miovský, M., Čablová, L., & Šťastná, L. (2015). Výskyt ADHD u osob závislých na ilegálních návykových látkách léčených v terapeutických komunitách v České republice-pilotní studie [ADHD in drug addicts undergoing treatment in Czech Therapeutic communities – A pilot study]. Česká a Slovenská Psychiatrie, 111(5), 228–235.
- Ryan, R. M., Plant, R. W., & O'Malley, S. (1995). Initial motivations for alcohol treatment: Relations with patient characteristics, treatment involvement, and dropout. Addictive Behaviors, 20(3), 279–297. https://doi.org/https://doi.org/10.1016/0306-4603(94)00072-7
- Simpson, D. D., & Joe, G. W. (1993). Motivation as a predictor of early dropout from drug abuse treatment. Psychotherapy: Theory, Research, Practice, Training, 30(2), 357–368. https://doi.org/https://doi.org/10.1037/0033-3204.30.2.357
- Simpson, D. D., Joe, G. W., Rowan-Szal, G., & Greener, J. (1995). Client engagement and change during drug abuse treatment. Journal of Substance Abuse, 7(1), 117–134. https://doi.org/https://doi.org/10.1016/0899-3289(95)90309-7
- Singmann, H. (2018). afex: Analysis of factorial experiments [R package]. https://cran.r-project.org/package=afex
- Stevens, L., Verdejo-García, A., Goudriaan, A. E., Roeyers, H., Dom, G., & Vanderplasschen, W. (2014). Impulsivity as a vulnerability factor for poor addiction treatment outcomes: A review of neurocognitive findings among individuals with substance use disorders. Journal of Substance Abuse Treatment, 47(1), 58–72. https://doi.org/https://doi.org/10.1016/j.jsat.2014.01.008
- The jamovi project. (2019). jamovi (Version 1.0) [Computer Software]. https://www.jamovi.org
- Timko, C., & Moos, R. H. (2002). Symptom severity, amount of treatment, and 1-year outcomes among dual diagnosis patients. Administration and Policy in Mental Health, 30(1), 35–54. https://doi.org/https://doi.org/10.1023/a:1021275516753
- van Emmerik-van Oortmerssen, K., Blankers, M., Vedel, E., Kramer, F., Goudriaan, A. E., van den Brink, W., & Schoevers, R. A. (2020). Prediction of drop-out and outcome in integrated cognitive behavioral therapy for ADHD and SUD: Results from a randomized clinical trial. Addictive Behaviors, 103, 106228. https://doi.org/https://doi.org/10.1016/j.addbeh.2019.106228
- van Emmerik-van Oortmerssen, K., van de Glind, G., van den Brink, W., Smit, F., Crunelle, C. L., Swets, M., & Schoevers, R. A. (2012). Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: A meta-analysis and meta-regression analysis. Drug Alcohol Depend, 122(1–2), 11–19. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2011.12.007
- Vanderplasschen, W., Colpaert, K., Autrique, M., Rapp, R. C., Pearce, S., Broekaert, E., & Vandevelde, S. (2013). Therapeutic communities for addictions: A review of their effectiveness from a recovery-oriented perspective. The Scientific World Journal, 2013, 1–22. https://doi.org/https://doi.org/10.1155/2013/427817
- Vanderplasschen, W., Yates, R., & Miovský, M. (2017). Bridging the gap between research and practice in therapeutic communities (TCs) for addictions. Journal of Groups in Addiction & Recovery, 12(2–3), 63–67. https://doi.org/https://doi.org/10.1080/1556035X.2017.1331598
- Volkow, N. D., Koob, G. F., & McLellan, A. T. (2016). Neurobiologic advances from the brain disease model of addiction. The New England Journal of Medicine, 374(4), 363–371. https://doi.org/https://doi.org/10.1056/NEJMra1511480
- Volkow, N. D., Wang, G.-J., Newcorn, J. H., Kollins, S. H., Wigal, T. L., Telang, F., Fowler, J. S., Goldstein, R. Z., Klein, N., Logan, J., Wong, C., & Swanson, J. M. (2011). Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway. Molecular Psychiatry, 16(11), 1147–1154. https://doi.org/https://doi.org/10.1038/mp.2010.97